AVr (n= 39) | AVR (n= 46) | P value | |
---|---|---|---|
Age (years) | 43.8± 8.6 | 49.6± 7.2 | 0.002 |
Males | 32 (82.1%) | 38 (82.6%) | 0.95 |
BMI (kg.m2) | 27.6 (24.2–32.3) | 29.4 (25.4–33) | 0.32 |
BSA (m2) | 1.9 (1.8- 2.) | 1.9 (1.9–2.1) | 0.09 |
NYHA class | <0.001 | ||
I | 13 (33.3%) | 2 (4.4%) | |
II | 24 (61.5%) | 25 (54.4%) | |
III | 2 (5.1%) | 18 (39.1%) | |
IV | 0 | 1 (2.2%) | |
CCS class | 0.03 | ||
I | 4 (10.3%) | 2 (4.4%) | |
II | 25 (64.1%) | 20 (43.5%) | |
III | 10 (25.6%) | 24 (52.2%) | |
Diabetes mellitus | 13 (33.3%) | 16 (34.8%) | 0.89 |
Hypercholesterolemia | 7 (18.9%) | 18 (40%) | 0.04 |
Hypertension | 17 (43.6%) | 31 (67.4%) | 0.03 |
Smokers | 1 (2.6%) | 9 (19.6%) | 0.02 |
Atrial fibrillation | 5 (12.8%) | 5 (10.9%) | 0.78 |
Hemoglobin (g/dl) | 13.5 (12.8–14.1) | 14.1 (12.2–15) | 0.42 |
Creatinine (mg/dl) | 0.9 (0.9–1.1) | 0.9 (0.8–1.1) | 0.74 |
Bilirubin (mg/dl) | 0.7± 0.2 | 0.6± 0.2 | 0.08 |
Ejection fraction | 0.85 | ||
˃50% | 31 (83.8%) | 37 (82.2%) | |
30–49% | 6 (16.2%) | 8 (17.8%) | |
Valve pathology | 0.15 | ||
Rheumatic | 24 (61.5%) | 35 (78.1%) | |
Degenerative | 15 (38.5%) | 11 (23.9%) | |
Valve lesion | <0.001 | ||
RCC prolapse | 9 (23.1%) | 1 (2.2%) | |
LCC prolapse | 3 (7.7%) | 2 (4.3%) | |
NCC prolapse | 18 (46.2%) | 10 (21.7%) | |
Two cusp prolapse | 1 (2.6%) | 2 (2.2%) | |
Root dilatation | 8 (20.5%) | 10 (21.7%) | |
Retracted cusp | 0 | 20 (43.5%) | |
Cusp prolapse and root dilatation | 0 | 1 (2.2%) |